Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Generic Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (163)
Cancellation by sponsor (126)
Prescription medicine registration (9)
Cancellation or suspension (7)
Australian public assessment report (AusPar) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2025 (13)
2024 (26)
2023 (23)
2022 (32)
2021 (15)
2020 (19)
2019 (23)
2018 (33)
2017 (17)
2016 (14)
2015 (10)
2014 (7)
2013 (13)
2012 (12)
2011 (17)
2010 (1)
2009 (6)
2008 (6)
2007 (16)
2006 (1)
2004 (2)
2001 (3)

Search

Sponsor content

309 result(s) found, displaying 51 to 60

ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack (370795)

16 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack.
ATOVAQUOPRO LUPIN 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet blister pack (370798)

16 August 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ATOVAQUOPRO LUPIN 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet blister pack.
RISPERIDONE GENERICHEALTH (Generic Health Pty Ltd)

5 September 2023

Prescription medicine registration

Active ingredients: risperidone.
ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe (364111)

22 June 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ICATIBANT LUPIN icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe.
ICATIBANT GH icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe (364112)

22 June 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ICATIBANT GH icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe.
URSODOX LUPIN ursodeoxycholic acid 250 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2023

Cancellation by sponsor

Requested by Generic Health Pty Ltd
ICATIBANT LAPL icatibant (as acetate) 30 mg/3 mL solution for injection pre-filled syringe Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Generic Health Pty Ltd
ATOVAQUOPRO LAPL 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Generic Health Pty Ltd
ATOVAQUOPRO LAPL 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Generic Health Pty Ltd
ATOVAQUOPRO LAPL 250/100 atovaquone/proguanil hydrochloride 250/100 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2023

Cancellation by sponsor

Requested by Generic Health Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.